Clinical presentations of parvovirus B19 infection

被引:2
|
作者
Servey, Jessica T.
Reamy, Brian V.
Hodge, Joshua
机构
[1] Family Med Clin, Travis AFB, CA 94535 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Although most persons with parvovirus B19 infection are asymptomatic or have mild, nonspecific, cold-like symptoms, several clinical conditions have been linked to the virus. Parvovirus B19 usually infects children and causes the classic "slapped-cheek" rash of erythema infectiosum (fifth disease). The virus is highly infectious and spreads mainly through respiratory droplets. By the time the rash appears, the virus is no longer infectious. The virus also may cause acute or persistent arthropathy and papular, purpuric eruptions on the hands and feet ("gloves and socks" syndrome) in adults. Parvovirus B19 infection can trigger an acute cessation of red blood cell production, causing transient aplastic crisis, chronic red cell aplasia, hydrops fetalis, or congenital anemia. This is even more likely in patients with illnesses that have already shortened the lifespan of erythrocytes (e.g., iron deficiency anemia, human immunodeficiency virus, sickle cell disease, thalassemia, spherocytosis). A clinical diagnosis can be made without laboratory confirmation if erythema infectiosum is present. If laboratory confirmation is needed, serum immunoglobulin M testing is recommended for immunocompetent patients; viral DNA testing is recommended for patients in aplastic crisis and for those who are immunocompromised. Treatment is usually supportive, although some patients may require transfusions or intravenous immune globulin therapy. Most patients recover completely.
引用
收藏
页码:373 / 376
页数:4
相关论文
共 50 条
  • [41] PRIMARY INFECTION BY HUMAN PARVOVIRUS B19
    TRATTNER, A
    DERMATOLOGY, 1994, 188 (02) : 169 - 169
  • [42] Parvovirus B19 infection and fulminant hepatitis
    Bernuau, J
    Durand, F
    Valla, D
    LANCET, 1999, 353 (9154): : 754 - 755
  • [43] Parvovirus B19 infection during pregnancy
    Crane, Joan
    Mundle, William
    Boucoiran, Isabelle
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2016, 38 (12) : S525 - S536
  • [44] Neurologic consequence of a parvovirus B19 infection
    Terhes, Gabriella
    Jenei, Marta
    Bereg, Edit
    Turi, Sandor
    Deak, Judit
    JOURNAL OF CLINICAL VIROLOGY, 2013, 56 (02) : 156 - 158
  • [45] Parvovirus B19 infection in pregnancy and amniocentesis
    Bogers, H.
    Cohen-Overbeek, T. E.
    Go, A. T. J. I.
    PRENATAL DIAGNOSIS, 2011, 31 (11) : 1109 - 1109
  • [46] Rheumatic manifestations of parvovirus B19 infection
    Naides, SJ
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (02) : 375 - +
  • [47] Atypical parvovirus B19 infection in a child
    Sebag, O
    Mas, JC
    Brun, P
    ARCHIVES DE PEDIATRIE, 1997, 4 (04): : 383 - 383
  • [48] Clinical presentation of parvovirus B19 infection in children with aplastic crisis
    Kellermayer, R
    Faden, H
    Grossi, M
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (12) : 1100 - 1101
  • [49] Clinical Course of Human Parvovirus B19 Infection in Hereditary Spherocytosis
    Urabe, Keisuke
    Inoue, Akiko
    Suzuki, Ryo
    Takitani, Kimitaka
    Ashida, Akira
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S74 - S75
  • [50] Human parvovirus B19 infection and autoimmunity
    Lunardi, Claudio
    Tinazzi, Elisa
    Bason, Caterina
    Dolcino, Marzia
    Corrocher, Roberto
    Puccetti, Antonio
    AUTOIMMUNITY REVIEWS, 2008, 8 (02) : 116 - 120